Jenna Bosco | Investor Relations |
Michael Weiss | Chairman and Chief Executive Officer |
Adam Waldman | Chief Commercialization Officer |
Sean Power | Chief Financial Officer |
Josh Schimmer | Evercore ISI |
Ed White | H. C. Wainwright |
Prakhar Agrawal | Cantor Fitzgerald |
Sahil Kazmi | B. Riley Securities |
Greetings, and welcome to the TG Therapeutics Fourth Quarter and Year-End 2022 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jenna Bosco.